Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
NCT Number: NCT06571058
This clinical trial tests how well the Bag Below Bladder (B3) Buddy device works in securing urinary drainage bags while walking. Keeping a urinary drainage bag below the bladder is the standard of care to maintain urine flow and prevent urine from backing up into the bladder. Despite the use of modern urinary drainage bags for over 60 years, workarounds, including hooking the bag into pants pockets, are being used to secure the bags while walking. The B3 Buddy may help keep the urinary drainage bag at the proper level for drainage while walking.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Columbus, Ohio, 43210, United States
PRIMARY OBJECTIVES:
I. To evaluate the acceptability of the B3 Buddy, from the patient's perspective.
II. To evaluate the usability of the B3 Buddy, from the clinician's perspective.
OUTLINE: Patients are assigned to 1 of 2 groups.
PATIENTS: Patients receive a short instructional session, wear the B3 Buddy device to secure urinary drainage bag and walk approximately 90 feet before urinary drainage bag is returned to the standard position on study.
CLINICIANS: Clinicians receive a short instructional session, secure the urinary drainage bag to the patient using the B3 Buddy device. Clinicians also assist patient with walking and then remove the device and return urinary drainage bag to the standard position on study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Assist patient with walking approximately 90 feet
Other names: Aid, Assist, Help
Receive a short instructional session
Other names: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational
Wear the B3 Buddy device
Secure the urinary drainage bag to the patient using the B3 Buddy device
Ancillary studies
Remove the device and return urinary drainage bag to the standard position
Other names: Removal
Walk approximately 90 feet
Other names: Ambulation, By Foot, On Foot, Walk
Time frame: Up to 17 minutes
The proportion of patients who find the device acceptable will be determined with the Acceptability of Implementation Measure tool. he AIM has 4 Likert items, ranging from 1 (for "completely disagree") to 5 (for "completely agree"). A higher number indicates greater acceptability. If a patient marked 3 or more items with at least a "4," the device was considered acceptable. The device will be considered acceptable if at least 70% of patient participants find the device acceptable, which will be calculated by survey responses.
Time frame: Up to 20 minutes
Clinicians perception of usability will be determined with the System Usability Scale. The System Usability Scale score ranges from 0 to 100, where 100 represents the highest possible perceived usability. The device will be considered usable if the overall mean score is 68 or greater, which will be calculated by survey responses.
Ohio State University Comprehensive Cancer Center
Other
Feasibility Testing of a Urinary Drainage Bag Securement Device to Improve Patient and Clinician Ambulation Experiences
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04731376
Endocrine System Diseases, Female Urogenital Diseases
Atlanta, Georgia, United States
View Trial DetailsNCT05834738
Autoimmune Diseases, Chronic Disease
Birmingham, Alabama, United States
View Trial DetailsNCT04114266
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Ghent, Belgium
View Trial DetailsNCT05086900
Behavior, Chronic Pain
Reading, Berkshire, United Kingdom
View Trial Details